DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

59.58 0.60 (1.02%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $59.58 1.02%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.25
Previous Close $58.98
Daily Range $59.01 - $59.90
52-Week Range $48.53 - $62.20
Market Cap $169.9B
P/E Ratio 32.05
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 17,319,362
Average Daily Volume 10,140,789
Current FY EPS $3.49





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug?

Diabetes affects more than 29 million Americans and can lead to a number of serious complications. However, this currently illegal drug could provide a new pathway for diabetics to achieve better glycemic balance.

Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way

GlaxoSmithKline plc has reported impressive late stage trial results for its shingles vaccine.

Zoetis: Betting The Proverbial Farm?

Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog

Tetraphase Spikes on Encouraging Data on Antibiotic - Analyst Blog

Merrill Lynch Top Healthcare Stock Picks for 2015

NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog

Battle In Hepatitis C Market: Bristol-Myers Squibb Needs To Speed Up

MRK Crosses Above Key Moving Average Level

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

See More MRK News...

MRK's Top Competitors

MRK $59.58 (1.02%)
Current stock: MRK
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY